Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - ATOSSA THERAPEUTICS, INC. | v301800_s1.htm |
| EX-3.1 - EXHIBIT 3.1 - ATOSSA THERAPEUTICS, INC. | v301800_ex3-1.htm |
| EX-3.3 - EXHIBIT 3.3 - ATOSSA THERAPEUTICS, INC. | v301800_ex3-3.htm |
| EX-10.1 - EXHIBIT 10.1 - ATOSSA THERAPEUTICS, INC. | v300180_ex10-1.htm |
| EX-10.3 - EXHIBIT 10.3 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-3.htm |
| EX-23.1 - EXHIBIT 23.1 - ATOSSA THERAPEUTICS, INC. | v301800_ex23-1.htm |
| EX-10.4 - EXHIBIT 10.4 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-4.htm |
| EX-10.6 - EXHIBIT 10.6 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-6.htm |
| EX-10.16 - EXHIBIT 10.16 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-16.htm |
| EX-10.11 - EXHIBIT 10.11 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-11.htm |
| EX-10.10 - EXHIBIT 10.10 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-10.htm |
| EX-10.15 - EXHIBIT 10.15 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-15.htm |
| EX-10.17 - EXHIBIT 10.17 - ATOSSA THERAPEUTICS, INC. | v301800_ex10-17.htm |
EXHIBIT
10.2
June 17,
2010
Robert
Kelly, President
Atossa
Genetics, Inc.
4105 E
Madison St, Suite 320
Seattle,
WA 98112
OBJECT: TERMINATION
OF EXCLUSIVE PATENT LICENSE AGREEMENT
Dear
Robert,
With this
letter, we hereby terminate the Exclusive Patent License Agreement between
Ensisheim Partners LLC (“Ensisheim”) and Atossa Genetics, Inc. (“Atossa”) dated
July 27, 2009. The reason for this termination is that we have agreed
that an assignment of all patent rights rather than a license is a better
business arrangement.
Upon
acceptance of this letter, Atossa will have no further obligation with respect
to royalty payments to Ensisheim. Any accrued but unpaid royalties
are immediately forgiven. Upon assignment, Atossa will have all
responsibility for prosecution, maintenance, and enforcement and will indemnify
Ensisheim from any and all claims against the patent
estate. Ensisheim will retain no residual rights with respect to the
patents and patent applications.
Thank you
for your immediate attention to this matter.
Sincerely
|
STEVEN
C. QUAY, M.D., PH.D.
|
|
|
/s/ Steven C.
Quay
|
|
|
Chairman
and CEO
|
|
|
Atossa
Genetics, Inc.
|
|
|
4105
E. Madison St, Suite 320
|
|
|
Seattle,
WA 98112
|
|
|
Accepted
on behalf of Atossa Genetics, Inc.
|
|
|
/s/ Robert Kelly
|
|
|
Robert
Kelly, President
|